These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6199618

  • 1. Effect of labetalol on preload in acute myocardial infarction with systemic hypertension.
    Renard M, Jacobs P, Melot C, Haardt R, Vainsel H, Bernard R.
    J Cardiovasc Pharmacol; 1984; 6(1):90-3. PubMed ID: 6199618
    [Abstract] [Full Text] [Related]

  • 2. Labetalol infusion in acute myocardial infarction with systemic hypertension.
    Marx PG, Reid DS.
    Br J Clin Pharmacol; 1979; 8(Suppl 2):233S-238S. PubMed ID: 526407
    [Abstract] [Full Text] [Related]

  • 3. [Hemodynamic effects of labetalol in patients with acute myocardial infarct and systemic arterial hypertension].
    Cantelli I, Lombardi G, Naccarella F, Pavesi PC, Bracchetti D.
    G Ital Cardiol; 1981; 11(1):110-8. PubMed ID: 7239092
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of hypertension in acute stage of myocardial infarction. Haemodynamic effects of labetalol.
    Renard M, Rivière A, Jacobs P, Bernard R.
    Br Heart J; 1983 Jun; 49(6):522-7. PubMed ID: 6849714
    [Abstract] [Full Text] [Related]

  • 5. Haemodynamic dose-response effects of intravenous labetalol in acute myocardial infarction.
    Nelson GI, Silke B, Ahuja RC, Hussain M, Taylor SH.
    Postgrad Med J; 1983 Jun; 59 Suppl 3():98-103. PubMed ID: 6647215
    [Abstract] [Full Text] [Related]

  • 6. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
    Dubourg O, Guéret P, Ferrier A, Léger P, Farcot JC, Rigaud M, Beaumont D, Bardet J, Bourdarias JP.
    Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
    [Abstract] [Full Text] [Related]

  • 7. [Hemodynamic effects of intravenous clonidine in patients with acute myocardial infarction].
    Foresti A, Massari FM, Moglia F, Lotto A.
    G Ital Cardiol; 1982 Feb; 12(11):767-74. PubMed ID: 6763571
    [Abstract] [Full Text] [Related]

  • 8. [Hemodynamic investigation, a logical approach to the treatment of acute myocardial infarction].
    Domenighetti G, Turini G, Perret C.
    Schweiz Med Wochenschr; 1980 Sep 27; 110(39):1406-11. PubMed ID: 7280589
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of arterial hypertension with labetalol. A polycentric study].
    G Ital Cardiol; 1982 Sep 27; 12(10):729-35. PubMed ID: 7182212
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diazoxide vs labetalol: a cross-over comparison of short-term effects in hypertension.
    Rumboldt Z, Bagatin J, Vidovic A.
    Int J Clin Pharmacol Res; 1983 Sep 27; 3(1):47-54. PubMed ID: 6679507
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S, Nielsen PE.
    Postgrad Med J; 1980 Sep 27; 56 Suppl 2():33-6. PubMed ID: 7433340
    [Abstract] [Full Text] [Related]

  • 14. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul 27; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 15. [Labetalol for the management of hypertensive crises during surgery of cerebral aneurysm; a haemodynamic study (author's transl)].
    Lüben V, Rieder W, Zierski J, Hempelmann G.
    Anasth Intensivther Notfallmed; 1981 Aug 27; 16(4):184-7. PubMed ID: 7294326
    [Abstract] [Full Text] [Related]

  • 16. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH.
    Pharmatherapeutica; 1981 Aug 27; 3(1):46-54. PubMed ID: 7033992
    [Abstract] [Full Text] [Related]

  • 17. [Sulmazole: a new positive inotropic agent].
    Renard M, Jacobs P, Melot C, Dresse A, Bernard R.
    Ann Cardiol Angeiol (Paris); 1984 Aug 27; 33(4):219-22. PubMed ID: 6465815
    [Abstract] [Full Text] [Related]

  • 18. [Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure].
    Engberding R, Bender F, Gülker H, Specker E, Molinski M.
    Z Kardiol; 1984 Aug 27; 73(8):498-503. PubMed ID: 6495809
    [Abstract] [Full Text] [Related]

  • 19. [Hemodynamic impact of pressotherapy].
    Dereppe H, Hoylaerts M, Renard M, Leduc O, Bernard R, Leduc A.
    J Mal Vasc; 1990 Aug 27; 15(3):267-9. PubMed ID: 2212870
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 27; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.